Hubert C. Chen
Chief Medical Officer, Pfenex Inc.
Companies
- Viking TherapeuticsChief Medical Officer Jun 3, 2026 to now1
- Forte Biosciences, Inc.Officer Jun 8, 2022 to Jan 3, 20242
- Metacrine, Inc.Chief Medical Officer Sep 15, 2020 to May 20, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Forte Biosciences, Inc.93,405 shares4Jan 1, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 1, 2024Shares withheld for tax 3,073 shares at $0.82 of Forte Biosciences, Inc.4
- Jan 1, 2024Exercised options 7,500 shares of Forte Biosciences, Inc.4
- Oct 1, 2023Shares withheld for tax 2,593 shares at $0.66 of Forte Biosciences, Inc.5
- Oct 1, 2023Exercised options 7,500 shares of Forte Biosciences, Inc.5
- Jul 31, 2023Granted 74,257 shares at $1.01 of Forte Biosciences, Inc.6
- Jul 1, 2023Shares withheld for tax 2,593 shares at $1.04 of Forte Biosciences, Inc.7
- Jul 1, 2023Exercised options 7,500 shares of Forte Biosciences, Inc.7
- Apr 1, 2023Shares withheld for tax 2,593 shares at $1.01 of Forte Biosciences, Inc.8
- Apr 1, 2023Exercised options 7,500 shares of Forte Biosciences, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARForte Biosciences, Inc., Officer
- 3
- 4
- 5SEC EDGARForm 4 filed Oct 3, 2023
- 6SEC EDGARForm 4 filed Aug 2, 2023
- 7SEC EDGARForm 4 filed Jul 5, 2023
- 8SEC EDGARForm 4 filed Apr 4, 2023